These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 23051605)

  • 1. Glial cell line-derived neurotrophic factor partially ameliorates motor symptoms without slowing neurodegeneration in mice with respiratory chain-deficient dopamine neurons.
    Sterky FH; Pernold K; Harvey BK; Lindqvist E; Hoffer BJ; Olson L
    Cell Transplant; 2013; 22(9):1529-39. PubMed ID: 23051605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SINEUP Non-coding RNA Targeting GDNF Rescues Motor Deficits and Neurodegeneration in a Mouse Model of Parkinson's Disease.
    Espinoza S; Scarpato M; Damiani D; Managò F; Mereu M; Contestabile A; Peruzzo O; Carninci P; Santoro C; Papaleo F; Mingozzi F; Ronzitti G; Zucchelli S; Gustincich S
    Mol Ther; 2020 Feb; 28(2):642-652. PubMed ID: 31495777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease.
    Bilang-Bleuel A; Revah F; Colin P; Locquet I; Robert JJ; Mallet J; Horellou P
    Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8818-23. PubMed ID: 9238061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologically controlled, discontinuous GDNF gene therapy restores motor function in a rat model of Parkinson's disease.
    Tereshchenko J; Maddalena A; Bähr M; Kügler S
    Neurobiol Dis; 2014 May; 65():35-42. PubMed ID: 24440408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient gene therapy for Parkinson's disease using astrocytes as hosts for localized neurotrophic factor delivery.
    Drinkut A; Tereshchenko Y; Schulz JB; Bähr M; Kügler S
    Mol Ther; 2012 Mar; 20(3):534-43. PubMed ID: 22086235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
    Zheng JS; Tang LL; Zheng SS; Zhan RY; Zhou YQ; Goudreau J; Kaufman D; Chen AF
    Brain Res Mol Brain Res; 2005 Mar; 134(1):155-61. PubMed ID: 15790539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glial cell line-derived neurotrophic factor receptor Rearranged during transfection agonist supports dopamine neurons in Vitro and enhances dopamine release In Vivo.
    Mahato AK; Kopra J; Renko JM; Visnapuu T; Korhonen I; Pulkkinen N; Bespalov MM; Domanskyi A; Ronken E; Piepponen TP; Voutilainen MH; Tuominen RK; Karelson M; Sidorova YA; Saarma M
    Mov Disord; 2020 Feb; 35(2):245-255. PubMed ID: 31840869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GDNF family ligands: a potential future for Parkinson's disease therapy.
    Mickiewicz AL; Kordower JH
    CNS Neurol Disord Drug Targets; 2011 Sep; 10(6):703-11. PubMed ID: 21838676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Focused Ultrasound Gene Therapy Approach Noninvasively Restores Dopaminergic Neuron Function in a Rat Parkinson's Disease Model.
    Mead BP; Kim N; Miller GW; Hodges D; Mastorakos P; Klibanov AL; Mandell JW; Hirsh J; Suk JS; Hanes J; Price RJ
    Nano Lett; 2017 Jun; 17(6):3533-3542. PubMed ID: 28511006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term glial cell line-derived neurotrophic factor overexpression in the intact nigrostriatal system in rats leads to a decrease of dopamine and increase of tetrahydrobiopterin production.
    Sajadi A; Bauer M; Thöny B; Aebischer P
    J Neurochem; 2005 Jun; 93(6):1482-6. PubMed ID: 15935064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adeno-associated virus type 2 vector-mediated glial cell line-derived neurotrophic factor gene transfer induces neuroprotection and neuroregeneration in a ubiquitin-proteasome system impairment animal model of Parkinson's disease.
    Du Y; Zhang X; Tao Q; Chen S; Le W
    Neurodegener Dis; 2013; 11(3):113-28. PubMed ID: 22626907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electroacupuncture Therapy Ameliorates Motor Dysfunction via Brain-Derived Neurotrophic Factor and Glial Cell Line-Derived Neurotrophic Factor in a Mouse Model of Parkinson's Disease.
    Pak ME; Ahn SM; Jung DH; Lee HJ; Ha KT; Shin HK; Choi BT
    J Gerontol A Biol Sci Med Sci; 2020 Mar; 75(4):712-721. PubMed ID: 31644786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-fold elevation of endogenous GDNF levels in mice improves motor coordination without causing side-effects.
    Mätlik K; Võikar V; Vilenius C; Kulesskaya N; Andressoo JO
    Sci Rep; 2018 Aug; 8(1):11861. PubMed ID: 30089897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An engineered zinc finger protein activator of the endogenous glial cell line-derived neurotrophic factor gene provides functional neuroprotection in a rat model of Parkinson's disease.
    Laganiere J; Kells AP; Lai JT; Guschin D; Paschon DE; Meng X; Fong LK; Yu Q; Rebar EJ; Gregory PD; Bankiewicz KS; Forsayeth J; Zhang HS
    J Neurosci; 2010 Dec; 30(49):16469-74. PubMed ID: 21147986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards a neuroprotective gene therapy for Parkinson's disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model.
    Björklund A; Kirik D; Rosenblad C; Georgievska B; Lundberg C; Mandel RJ
    Brain Res; 2000 Dec; 886(1-2):82-98. PubMed ID: 11119690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective mechanisms by glial cell line-derived neurotrophic factor and cerebral dopamine neurotrophic factor against the α-synuclein accumulation in Parkinson's disease.
    Er S; Airavaara M
    Biochem Soc Trans; 2023 Feb; 51(1):245-257. PubMed ID: 36794783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged Parkinsonian rat.
    Connor B; Kozlowski DA; Schallert T; Tillerson JL; Davidson BL; Bohn MC
    Gene Ther; 1999 Dec; 6(12):1936-51. PubMed ID: 10637445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenoviral vector-mediated delivery of glial cell line-derived neurotrophic factor provides neuroprotection in the aged parkinsonian rat.
    Connor B
    Clin Exp Pharmacol Physiol; 2001 Nov; 28(11):896-900. PubMed ID: 11703392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral vector delivery of neurotrophic factors for Parkinson's disease therapy.
    Kelly MJ; O'Keeffe GW; Sullivan AM
    Expert Rev Mol Med; 2015 May; 17():e8. PubMed ID: 25997719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GDNF fails to exert neuroprotection in a rat α-synuclein model of Parkinson's disease.
    Decressac M; Ulusoy A; Mattsson B; Georgievska B; Romero-Ramos M; Kirik D; Björklund A
    Brain; 2011 Aug; 134(Pt 8):2302-11. PubMed ID: 21712347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.